Xilio Therapeutics Competitors and Similar CompaniesClear all
Xilio Therapeutics's competitors and similar companies include Alligator Bioscience.
 Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. | ||
Founding Date | Founding Date 2015 | Founding Date 2001 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations Lund, SE HQ |
Employees | Employees 69 | Employees 1555% decrease |
Valuation ($) | Valuation ($) 43.5 m | Valuation ($) 59 m |
Financial | ||
Revenue (est.) | Revenue (est.) $43.8m (FY, 2025) | Revenue (est.) kr514k (FY, 2025) |
Net income | Net income ($35m) (FY, 2025) | Net income (kr51.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Alligator Bioscience
HQ
Lund, SE
Employees
15
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View company